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Abstract. The objective of this study was to evaluate the effects of hydroxyethyl starch, (130/0.4) 6%, 
compared to Ringer’s acetate and modified gelatin on hypoxemia, inflammatory response, and oxidative 
stress in an experimental model of acute lung injury (ALI).  The ALI/Adult Respiratory Distress Syndrome 
(ARDS) experimental model was produced by a bronchoalveolar saline lavage. Mature New Zealand white 
rabbits were anesthetized, provided with a tracheostomy and vascular catheters, and randomized to receive 
25 ml/kg/hr of Ringer’s acetate (group R, n = 7), 25 ml/kg/hr of modified gelatin (group G, n = 7), or  25 
ml/kg/hr of hydroxyethyl starch (group S, n = 7). All of the rabbits received mechanical ventilation to 
maintain the PaCO2 between 35 and 45 mm Hg. Blood gas levels and hemodynamic values were recorded 
before induction of lung injury (T0) and 10 (T10), 120 (T120) and 240 (T240) min following induction 
of lung injury. At the same time-points, blood samples were collected to measure the plasma levels of 
TNFα (tumor necrosis factor-alpha) and TBARS (thiobarbituric acid-reactive substances). The experiment 
yielded the following results: The blood PaO2/FiO2 ratio was higher in group S than in groups R and G at 
T10, T120, and T240 (p <0.05). In group S, the plasma TNFα and TBARS concentrations were lower 
than in groups R and G at T120 and T240 (p <0.05). In conclusion, rabbits treated with hydroxyethyl 
starch, (130/0.4) 6%, demonstrated reductions of hypoxemia, inflammatory response, and oxidative lung 
damage, compared to raabbits treated with Ringer’s acetate or modified gelatin.
Keywords:  acute lung injury, respiratory failure, inflammation, lung disease, broncoalveolar lavage, 
hydroxyethyl starch
Introduction
Acute Lung Injury (ALI)/Adult Respiratory Distress 
Syndrome (ARDS) is characterized by an alteration 
of pulmonary capillary permeability that facilitates 
the passage of fluids and activated inflammatory 
cells into the interstitial tissues and ultimately into 
the alveoli themselves [1,2]. Interstitial edema and 
inflammatory parenchymal damage cause severe 
hypoxemia, which is often refractary to oxygen 
therapy. Pulmonary injuries are followed by 
fibroblast proliferation, collagen deposition, and 
fibrosis, which impair the respiratory exchange in 
advanced stages of the disease [1].
 Recently, experimental evidence has suggested 
a beneficial  effect of hydroxyethyl starch in 
reducing interstitial edema due to systemic inflam-
matory response, through various mechanisms: 
fluid reabsorption in the interstitium [3,4]; down-
regulation of inflammatory mediators [5-9] 
sustained by  suppression of NF-kappaB activation 
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[10-13], and sealing of the microcirculatory 
endothelial lesions, which seems to reduce the 
extravascular leak of fluids and inflammatory cells 
[14,15]. A number of studies have demonstrated 
that treatment with hydroxyethyl starch is associated 
with decreased capillary permeability in an animal 
model of fecal peritonitis [3], in neonatal 
cardiopulmonary bypass [4], and in trauma [16].
These considerations support our hypothesis that 
administration of hydroxyethyl starch could be 
more effective in reducing oxidative stress in acutely 
injured lungs, compared to administration of 
Ringer’s acetate or modified gelatin.  To test this 
hypothesis we performed a prospective study in an 
animal model of respiratory failure treated with 
hydroxyethyl starch (130/0.4) 6%, Ringer’s acetate, 
or modified gelatin. Plasma concentrations of 
TNFα (Tumor Necrosis Factor alpha) and TBARs 
(Thiobarbituric Acid Reactants) were measured as 
indicators of inflammatory response and oxidative 
stress during in the initial stage of the syndrome.
Materials and Methods
The experimental protocol was designed in compliance with 
the recommendations of the European Economic Community 
(86/609/CEE) for the care and use of laboratory animals and 
was approved by the Animal Care Committee of the University 
of Florence. The study was conducted on 21 New Zealand 
albino rabbits, weighing 2.2 to 3.5 kg. General anesthesia was 
induced with ketamine (10 mg/kg, im) and midazolam (1 
mg/kg, im) and maintained by continuous iv infusion of 
propofol (3 mg/kg/hr) and ketamine (10 mg/kg/hr). A 
catheter was placed in an ear vein for hydration fluid and drug 
administration during the experiment. The rabbits were 
preoxygenated during spontaneous breathing with 100% 
oxygen by facial mask.
 The anterior neck was dissected and a tracheotomy was 
performed in order to position a neonatal cuffless tracheostomy 
tube (size 3, internal diameter 3.0 mm, Shiley, Irvine, CA, 
USA). Once the tracheal cannula was inserted, muscle 
paralysis was induced by pancuronium bromide (0.2 mg/kg, 
iv) and maintained with 0.1 mg/kg doses every 30 min. The 
rabbits were mechanically ventilated using a neonatal 
pressure-controlled  ventilator (Bear Cub 750 psv, Life 
Medical Equipment Inc., Miami, FL, USA) at peak pressure 
(PP) 10 cm H2O, respiratory rate (RR) 40 breaths/min, 
positive end-expiratory pressure (PEEP) 2 cm H2O, and FiO2 
0.7. Mechanical ventilation lasted 240 ± 10 min. During the 
procedure, the ECG was monitored continuously and arterial 
blood pressure was recorded using a catheter inserted in the 
carotid artery and connected to a transducer. After the initial 
blood gas analysis, the minute volume was set to maintain 
PaCO2 between 35 and 45 mm Hg by modifying the peak 
pressure value to between 10 and 20 cm H2O). The other 
ventilator parameters were unchanged.
 Lung injury was induced by performing repeated 
pulmonary lavages with 0.9% saline solution (20 ml/kg) 
instilled in the tracheostomy tube through a small catheter, as 
described by Lachmann et al [17]. The following parameters 
were monitored every 30 min with a blood gas analyzer 
(Radiometer ABL 610, Copenhagen, Denmark): PaCO2 (mm 
Hg), PaO2 (mm Hg), BE (mmol/m), bicarbonate (mmol/l), 
pH, and hemoglobin (g/dl). PaO2/FiO2  values were computed 
using the ratio between the PaO2 value from the blood gas 
analysis and the FiO2 setting on the ventilator. Hemodynamic 
parameters were recorded before the induction of lung injury 
(T0), and at 10 (T10), 120 (T120), and 240 (T240) min after 
induction of lung injury.  During the experiment, the rabbits 
were treated with ethylephedrine in case of severe hypotension 
(<60 mm Hg), atropine in case of bradycardia (0.01 mg), and 
sodium bicarbonate to correct metabolic acidosis (blood pH 
<7.25).  At the end of the experiment, the rabbits were killed 
with a lethal dose of potassium chloride.
 The rabbits were randomly assigned to 3 experimental 
groups: Group R (n = 7), infusion of Ringer’s acetate at 25 
ml/kg/hr; Group G (n = 7), infusion of modified gelatin at 25 
ml/kg/hr; and Group S (n = 7): infusion of  hydroxyethyl 
starch, (130/0.4) 6%, at 25 ml/kg/hr. Arterial blood samples 
(4 ml) from each rabbit at T0, T10, T120, and T240 were 
drawn in Vacutainer tubes containing EDTA and centrifuged 
at 4,000 x g for 10 min. The plasma was removed and stored 
at -80°C for measurements of TNFα and TBARS. 
 Plasma TNFα was assayed with the Hybridomus solid-
phase ELISA kit (Patricell Ltd., Nottingham, UK) and a 
microtiter plate spectrophotometer (Perkin-Elmer, Norwalk, 
CT, USA). A standard curve was prepared by plotting the 
absorbance vs concentration of TNFα (pg/ml) in standards. 
Plasma TNFα levels were determined by comparing the 
absorbances of unknown samples to the standard curve.
 Plasma thiobarbituric acid reactant substances  (TBARS) 
were measured using  a MDA kit (Sobioda, Grenoble, France). 
Malondialdehyde (MDA) was reacted with thiobarbituric 
acid (TBA) to form a red MDA-TBA adduct [19], which was 
extracted into butanol and measured by spectrophotometry at 
546 nm. 
Statistics. Heart rate, arterial pressure, blood hemoglobin, 
pH, bicarbonate, PaO2, PaCO2, TNFα, and TBARS values 
at T0, T10, T120, and T240 in the 3 experimental groups 
were expressed as means ± SD.  Comparison of the means of 
the 3 groups at each time-point was performed by ANOVA 
for 3 independent samples (p <0.05 was deemed significant).
 
Results
The mean Systolic arterial Pressure (SaP) was lower 
(p <0.05) in group R compared to groups G and S 
at 10 and 120 min of ventilatory  support after lung 
injury (Table 1); the mean Diastolic arterial Pressure 
(DaP) was significantly lower in group R at 10 min 
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Table 1. Hemodynamic and blood hemoglobin data in the R, G, and S groups at 0, 10, 120, and 240 min after the induction 
of lung injury (means ± SD; ns = not significant).
Parameter Group R Group G Group S p by
and time (Ringer’s acetate) (modified gelatin) hydroxyethyl starch ANOVA
HR (beats/min)
 T0 216±16 266±40 242±61 ns
 T10 213±14 290±36 249±28 ns
 T120 229±27 250±29 233±42 ns 
 T240 202±30 235±38 228±37 ns
SaP (mm Hg)
 T0 98±18 113±8 108±22 ns
 T10 89±19 111±11 120±19 <0.05
 T120 92±16 119±12 113±16  <0.05
 T240 105±20 133±32 110±22  ns 
DaP (mm Hg)
 T0 75±13 85±8 77±18 ns
 T10 67±19 86±7 90±11 <0.05
 T120 71±11 87±12 81±16 ns
 T240 82±21 83±7 82±19 ns 
Hb (g/dl)
 T0 12.0±2.2 10.7±1.8 10.2±2.9 ns  
 T10 11.0±2.0 10.0±1.5 9.0±2.7 ns
 T120 11.0±2.8 8.4±1.4 7.1±2.1 <0.05
 T240 9.3±5.3 8,1±2.1 7,1±1.8 ns 
compared to the other 2 groups.  At 120 min after 
lung injury, blood hemoglobin (Hb) concentration 
(Table 1) was significantly higher in group R, 
compared to the other 2 groups. 
 There were no significant differences in blood 
pH, BE, bicarbonate, and PaCO2 among the 3 
groups during the experimental period (times 0, 
10, 120, 240 min), but the PaO2  and PaO2/FiO2 
ratio decreased after the lung injury (Table 2). PaO2 
was significantly higher in group S compared to 
groups R and G at 120 and 240 min. The PaO2/
FiO2 ratio (Table 2, Fig. 1) was significantly higher 
in group S compared to the other 2 groups at 10, 
120, and 240 min.  After broncoalveolar lavage, 
the plasma TNFα and TBARS concentrations 
increased in all groups (Table 3, Figs. 2 and 3), but 
were significantly lower in group S compared to 
groups R and G at 120 and 240 min.
Discussion
The major pathophysiologic mechanisms of ALI/
ARDS  are: (a) parenchymal lung damage inducing 
inadequate pulmonary gas exchange, hypoxemia, 
reduction of lung compliance, and increased airway 
resistance, and (b) pulmonary aggregation of 
inflammatory cells and release of mediators that 
cause further endothelial and parenchymal damage 
[18]. Based on these considerations, we postulated 
that an animal model of ALI/ARDS with hypox-
emia and hemodynamic instability might be a 
suitable model for this investigation.
 Lachmann et al [17] observed severe disturbance 
of pulmonary function parameters, decrease of 
dynamic compliance, and increases of both 
inspiratory and expiratory pulmonary resistance in 
an experimental model of ALI/ARDS that was 
produced by bronchoalveolar lavage with saline 
solution, which depletes the alveolar surfactant and 
causes lesions similar to ARDS in the pulmonary 
parenchyma and in the microcirculation. 
Microscopic study of histologic lung sections 
showed focal and diffuse atelectasis, desquamation 
of  bronchial and bronchiolar epithelial cells, and 
presence of hyaline membranes in the preterminal 
airways [17]. In addition, signs of peribronchial 
inflammation with edema and infiltration of 
leukocytes and eosinophils were observed. This 
resemblance between clinical and experimentally-
induced ARDS indicates the validity of reproducing 
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Table 2. Arterial blood gas data and Pa)2/Fi)2 ratio in the R, G, and S groups at 0, 10, 120, and 240 min after the induction of 
lung injury (means ± SD; ns = not significant).
Parameter Group R Group G Group S p by
and time (Ringer’s acetate) (modified gelatin) hydroxyethyl starch ANOVA
pH 
 T0 7.35±0.12 7.34±0.02 7.35±0.09 ns
 T10 7.16±0.11 7.25±0.10 7.27±0.09 ns
 T120 7.23±0.09 7.31±0.08 7.24±0.10 ns
 T240 7.21±0.16 7.25±0.09 7.32±0.06  ns 
PaO2 (mm Hg)
 T0 427.6±147.9 377.1±78.9 373.7±134.4 ns
 T10 118.3±88.5 78.3±18.4 187.0±130.4 ns
 T120 74.1±27.1 67.5±26.0 168.8±102.1 <0.05
 T240   103.4±68.9 94.3±48.7 228.9±109.5  <0.05 
PaCO2 (mm Hg)
 T0 26.5±8.9 38.2±3.8 31.2±7.5 ns 
 T10 44.7±19.8 51.8±8.3 41.8±11.3 ns
 T120 50.7±4.5   44.2±9.7 44.4±10.1 ns
 T240 45.4±10.7 47.7±10.4 39.2±4.9  ns 
PaO2/FiO2 
 T0 503±104 501±65 463±142 ns
 T10 141±117 109±34 274±155 <0.05
 T120 90±49    96±38 233±132 <0.05
 T240 108±79 120±69 312±129 <0.05 
HCO3 (mmol/L)
 T0 13.45±3.60 20.34±4.28 17.02±2.37 ns
 T10 21.10±5.55 21.38±3.32 18.99±2.94 ns
 T120 21.18±5.38 21.37±3.54 19.58±2.45 ns
 T240 18.24±5.73 20.54±2.06 19.99±2.09 ns 
BE (mmol/L)
 T0 -11.44±5.91 -4.38±4.38 -7.53±2.73 ns 
 T10 -8.51±5.82 -4.96±4.36 -6.68±3.58 ns
 T120 -5.23±5.80 -4.01±3.92 -6.80±2.36 ns
 T240 -8.26±8.11 -5.62±2.89 -4.35±4.25 ns
Table 3. Plasma levels of TNFα and TBARS in the R, G, and S groups at 0, 10, 120, and 240 min after the induction of lung 
injury (means ± SD; ns = not significant).
Parameter Group R Group G Group S p by
and time (Ringer’s acetate) (modified gelatin) hydroxyethyl starch ANOVA
TNFα (pg/ml) 
 T0 13.52±5.7 10.04±5.0 10.52±5.4 ns 
 T10 27.02±9.9 23.09±15.3 14.46±5.4 ns 
 T120 29.04±12.5 22.90±17.8 11.69±2.4 <0.05 
 T240 26.33±10.8 21.87±10.8 12.58±5.8 <0.05
TBARS (μmol/L) 
 T0 0.78±0.3 0.69±0.3 0.49±0.4 ns 
 T10 1.12±0.5 0.85±0.3 0.52±0.3 ns
 T120 1.75±0.5 1.05±0.2 0.69±0.69 <0.05
 T240 1.65±0.5 1.14±0.3 0.75±0.4  <0.05 
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Fig. 1. Values of PaO2/FiO2 ratio in the 
experimental model of ALI/ARDS obtained 
with bronchoalveolar lavage. Group R: 
rabbits treated with Ringer’s acetate. Group 
G: rabbits treated with modified gelatin. 
Group S: rabbits treated with hydroxyethyl 
starch (130/0.4) 6%.
* =  p < 0.05 by ANOVA.
Fig. 2. Plasma TNFα levels (pg/ml) of 
rabbits with ALI/ARDS produced by 
bronchoalveolar lavage. Group R: rabbits 
treated with Ringer’s acetate. Group G: 
rabbits treated with modified gelatin. 
Group S: rabbits treated with hydroxyethyl 
starch (130/0.4) 6%. 
* =  p < 0.05 by ANOVA.
Fig. 3. Plasma TBARS levels  (μmol/L) of 
rabbits with ALI/ARDS produced by 
bronchoalveolar lavage. Group R: rabbits 
treated with Ringer’s acetate. Group G: 
rabbits treated with modified gelatin. 
Group S: rabbits treated with hydroxyethyl 
starch (130/0.4) 6%.
 * =  p < 0.05  by ANOVA.
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modifications in blood gas parameters, pulmonary 
function, and histopathological changes [20].
 We choose the model proposed by Lachmann 
et al [17] because, compared to other models, it has 
the following advantages: ease of application and 
repetition and an ability to reproduce the alterations 
of ventilation/perfusion ratio that are characteristic 
of ALI/ARDS. Hydroxyethyl starch has been 
shown to reduce the inflammatory response and 
interstitial edema caused by increased capillary 
permeability in various clinical and experimental 
studies [3-16].  The mechanism is not completely 
known, but Zikria et al [15] suggested a  biophysical 
mechanism of action that they described as a 
sealing effect; ie, macromolecules of adequate form 
and dimension could help in the repair of capillary 
endothelium by sealing the pores between cellular 
junctions. 
 Hoffmann and coworkers [21], analyzing the 
rolling and adherence of leukocytes and the 
microhemodynamics in postcapillary venules by 
intravital fluorescence microscopy, observed a 
relevant protective effect of hydroxyethyl starch on 
endotoxin-induced microcirculatory disorder in 
vivo. They reported that hydroxyethyl starch, 
(130/0.4) 6%, was more effective than saline in 
preventing LPS-induced leukocyte adherence, 
capillary perfusion failure, and reducing LPS-
induced macromolecular leakage [21]. Marx et al 
[22] tested the effects of hydroxyethyl starch (HES 
130 kD) and Ringer’s solution (RS) on plasma 
volume (PV) maintenance in a porcine model of 
intraperitoneal septic shock. In this model, HES 
130 kD, but not RS, was effective in maintaining 
PV and preserving systemic hemodynamics and 
oxygenation [22].
 Many studies have demonstrated essential roles 
of inflammatory cytokines in modulating the 
clinical findings of ALI/ARDS.  Experimental 
infusion of TNFα in animals causes intense 
margination and migration of  neutrophils through 
the walls of the pulmonary vessels, thrombotic 
occlusion of large arteries, significant increase of 
pulmonary permeability, hypoxemia, pulmonary 
hypertension, and decrease of  dynamic compliance 
[23]. Furthermore, TNFα increases neutrophil 
degranulation and superoxide production, which 
causes tissue injury [24]. Free radical-induced oxid-
ation of membrane lipids leads to the formation of 
cytotoxic aldehydes, which are degradation 
products of lipid hydroperoxides. These aldehydes 
are relatively stable yet biologically active, and may 
therefore be considered as cytotoxic second messen-
gers. Since they originate from free radical-induced 
reactions with cellular lipids, the presence of these 
aldehydes is considered a marker of a recent free 
radical-mediated reaction; consequently, an increase 
in cytotoxic aldehyde concentrations implies that 
oxidative stress occurred. 
 Among the analytical approaches for the 
estimation of oxygen radical-mediated damage in 
biological systems, determination of malondialde-
hyde (MDA) has been employed most commonly. 
In biological matrices, MDA exists both free and 
bound to SH and NH2 groups of proteins and 
nucleic acids [25]. Usually the total (free and 
bound) MDA is evaluated by assay of thiobarbituric 
acid-reactant substances (TBARS) [26].
 Several authors have reported that hydroxyethyl 
starch inhibits tissue NF-kappaB activation during 
sepsis induced by administration of  lipopolysac-
charide in rats [10-13] or in the model of sepsis 
induced by cecal ligation and puncture [14]. The 
inhibition of NF-kappaB activation results in lower 
plasma TNFα concentration, less pulmonary 
capillary permeability, and reduced free radical 
production.
 Since interstitial edema and increased pulmon-
ary capillary permeability represent pathogenic 
situations that are essential to the development of 
ALI/ARDS, in the present study we used the model 
of bronchoalveolar saline lavage to evaluate the 
efficacy of hydroxyethyl starch, (130/0.4) 6%, in 
the initial phase of acute respiratory syndrome, and 
its ability to limit progression toward ARDS. 
Hydroxyethyl starch was compared with Ringer’s 
acetate and another commonly used colloid (ie, 
modified gelatin) with the aim of establishing 
whether the therapeutic efficacies of these oncotic 
agents were significantly different.  Koustova et al 
[27] demonstrated that Ringer’s lactate increased 
the production of oxygen reactive species by 
neutrophils and the expression of leukocytes 
involved in the inflammatory response, cellular 
migration, and apoptosis. For this reason, in the 
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present study, we infused the rabbits with Ringer’s 
acetate instead of Ringer’s lactate.
 Protective effects of hydroxyethyl starch against 
hypoxemia were shown in our study by the 
improved PaO2/FiO2 ratio, the lower plasma 
TNFα level, and the lower plasma TBARS level in 
group S, compared to groups R and G. The hemo-
dynamic parameters overlapped in the 3 groups, 
with the exception of systolic pressure, which was 
lower in the Ringer’s acetate group at T10 and 
T120 compared to the other groups. This probably 
was due to the effect of the greater plasma volume 
conferred by the two oncotic agents, which was 
also indicated by a lower diastolic pressure at T10.
 Blood hemoglobin level was significantly 
higher in group R at T120 compared with the other 
groups. This result may be related to the oncotic 
effect of hydroxyethyl starch and  gelatin. At all 
time-points, blood hemoglobin was lower in group 
S than group G, but these differences were not 
significant. The blood pH, BE, bicarbonate and 
PaCO2 values in the 3 groups were not significantly 
different at any of the observation times.
 The blood PaO2/FiO2 ratio was  higher  in the 
hydroxyethyl starch-treated group compared to the 
Ringer’s acetate- or modified gelatin-treated groups. 
The results for TNFα and oxygen free radical prod-
uction demonstrate a major phlogistic reaction in 
rabbits treated with Ringer’s acetate and modified 
gelatin compared to the rabbits treated with 
hydroxyethyl starch. 
 Our results confirm an anti-inflammatory 
effect of hydroxyethyl starch during experimental 
ALI/ARDS, which has been noted by other authors 
in various experimental model of sepsis, in 
comparison to crystalloids and gelatin. The use of 
hydroxyethyl starch, (130/0.4) 6%, in the initial 
phases of respiratory insufficiency appears to protect 
against the progression of the syndrome, by amelior-
ating hypoxemia and the inflammatory response to 
pulmonary insult.
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